Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-13 2:09 pm Purchase | 2025-06-09 | 13G | Aytu BioPharma, Inc. AYTU | LYTTON LAURENCE W | 506,605 5.600% | 506,605 (New Position) | Filing History |
| 2025-05-16 5:41 pm Purchase | 2025-05-12 | 13G | Sonim Technologies, Inc. SONM | LYTTON LAURENCE W | 2,066,916 19.300% | 1,200,000 (+138.42%) | Filing History |
| 2025-05-15 3:51 pm Sale | 2025-03-31 | 13G | Evoke Pharma, Inc. EVOK | LYTTON LAURENCE W | 61,274 3.900% | -13,483 (-18.04%) | Filing History |
| 2025-05-15 3:50 pm Sale | 2025-03-31 | 13G | SmartKem, Inc. SMTK | LYTTON LAURENCE W | 222,721 4.900% | -110,612 (-33.18%) | Filing History |
| 2025-05-15 3:49 pm Sale | 2025-03-31 | 13G | NeuroOne Medical Technologies Corporation NMTC | LYTTON LAURENCE W | 1,295,288 2.600% | -764,634 (-37.12%) | Filing History |
| 2025-05-15 3:29 pm Sale | 2025-03-31 | 13G | Creative Realities, Inc. CREX | LYTTON LAURENCE W | 524,363 5.000% | -137,028 (-20.72%) | Filing History |
| 2025-05-15 3:27 pm Sale | 2025-03-31 | 13G | Biofrontera Inc. BFRI | LYTTON LAURENCE W | 306,700 3.500% | -248,184 (-44.73%) | Filing History |
| 2025-04-16 2:11 pm Purchase | 2025-04-15 | 13G | Xtant Medical Holdings, Inc. XTNT | LYTTON LAURENCE W | 9,463,442 6.800% | 9,463,442 (New Position) | Filing History |
| 2025-02-24 11:48 am Purchase | 2025-02-20 | 13G | Sonim Technologies, Inc. SONM | LYTTON LAURENCE W | 866,916 17.800% | 401,400 (+86.23%) | Filing History |
| 2025-02-13 3:55 pm Sale | 2024-12-31 | 13G | Creative Realities, Inc. CREX | LYTTON LAURENCE W | 661,391 6.300% | -122,609 (-15.64%) | Filing History |
| 2025-02-13 3:49 pm Sale | 2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | LYTTON LAURENCE W | 3,955,470 8.800% | -434,499 (-9.90%) | Filing History |
| 2025-02-13 3:45 pm Purchase | 2024-01-31 | 13G | Duos Technologies Group, Inc. DUOT | LYTTON LAURENCE W | 427,002 4.990% | 26,434 (+6.60%) | Filing History |
| 2025-02-13 3:31 pm Purchase | 2024-12-31 | 13G | MDxHealth SA MDXH | LYTTON LAURENCE W | 3,949,385 8.400% | 1,058,790 (+36.63%) | Filing History |
| 2025-02-13 3:26 pm Sale | 2024-12-31 | 13G | EMCORE Corporation EMKR | LYTTON LAURENCE W | 126,948 1.400% | -359,537 (-73.91%) | Filing History |
| 2025-02-05 4:16 pm Purchase | 2025-01-30 | 13G | Sonim Technologies, Inc. SONM | LYTTON LAURENCE W | 465,516 9.600% | 465,516 (New Position) | Filing History |
| 2024-12-23 6:52 pm Purchase | 2024-12-20 | 13G | SmartKem, Inc. SMTK | LYTTON LAURENCE W | 333,333 9.400% | 333,333 (New Position) | Filing History |
| 2024-12-23 6:51 pm Purchase | 2024-12-17 | 13G | Electrovaya Inc. ELVA | LYTTON LAURENCE W | 2,443,309 6.200% | 2,443,309 (New Position) | Filing History |
| 2024-11-26 08:42 am Purchase | 2024-09-30 | 13G | NeuroOne Medical Technologies Corporation NMTC | LYTTON LAURENCE W | 2,059,922 6.600% | 755,820 (+57.96%) | Filing History |
| 2024-11-14 3:58 pm Purchase | 2024-09-30 | 13G | scPharmaceuticals Inc. SCPH | LYTTON LAURENCE W | 2,944,932 5.900% | 1,119,698 (+61.35%) | Filing History |
| 2024-11-14 1:26 pm Purchase | 2024-09-30 | 13G | Cellectar Biosciences, Inc. CLRB | LYTTON LAURENCE W | 4,389,969 9.990% | 1,109,791 (+33.83%) | Filing History |